H. Lundbeck A/S
H. Lundbeck A/S (HLUBF) Stock Competitors & Peer Comparison
See (HLUBF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLUBF | $5.37 | -2.36% | 5.7B | 9.26 | $0.58 | +3.31% |
| MKGAF | $148.62 | -1.80% | 67.6B | 22.92 | $6.78 | +1.66% |
| MKKGY | $30.09 | +0.82% | 65B | 22.14 | $1.35 | +1.73% |
| IPSEY | $46.60 | -4.43% | 62.1B | 30.28 | $1.55 | +0.85% |
| TKPHF | $32.10 | -1.53% | 50.7B | 42.80 | $0.75 | +4.06% |
| HLNCF | $4.63 | -3.14% | 40.9B | 18.46 | $0.25 | +2.07% |
| SDZNY | $81.90 | -0.17% | 35.8B | 39.61 | $2.09 | +1.23% |
| TEVJF | $30.19 | +0.00% | 35.2B | 24.95 | $1.21 | N/A |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
Stock Comparison
HLUBF vs MKGAF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, MKGAF has a market cap of 67.6B. Regarding current trading prices, HLUBF is priced at $5.37, while MKGAF trades at $148.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas MKGAF's P/E ratio is 22.92. In terms of profitability, HLUBF's ROE is +0.15%, compared to MKGAF's ROE of +0.08%. Regarding short-term risk, HLUBF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check MKGAF's competition here
HLUBF vs MKKGY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, MKKGY has a market cap of 65B. Regarding current trading prices, HLUBF is priced at $5.37, while MKKGY trades at $30.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas MKKGY's P/E ratio is 22.14. In terms of profitability, HLUBF's ROE is +0.15%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, HLUBF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check MKKGY's competition here
HLUBF vs IPSEY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, IPSEY has a market cap of 62.1B. Regarding current trading prices, HLUBF is priced at $5.37, while IPSEY trades at $46.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas IPSEY's P/E ratio is 30.28. In terms of profitability, HLUBF's ROE is +0.15%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, HLUBF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
HLUBF vs TKPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TKPHF has a market cap of 50.7B. Regarding current trading prices, HLUBF is priced at $5.37, while TKPHF trades at $32.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TKPHF's P/E ratio is 42.80. In terms of profitability, HLUBF's ROE is +0.15%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, HLUBF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
HLUBF vs HLNCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HLNCF has a market cap of 40.9B. Regarding current trading prices, HLUBF is priced at $5.37, while HLNCF trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HLNCF's P/E ratio is 18.46. In terms of profitability, HLUBF's ROE is +0.15%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, HLUBF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check HLNCF's competition here
HLUBF vs SDZNY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SDZNY has a market cap of 35.8B. Regarding current trading prices, HLUBF is priced at $5.37, while SDZNY trades at $81.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SDZNY's P/E ratio is 39.61. In terms of profitability, HLUBF's ROE is +0.15%, compared to SDZNY's ROE of +0.09%. Regarding short-term risk, HLUBF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check SDZNY's competition here
HLUBF vs TEVJF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TEVJF has a market cap of 35.2B. Regarding current trading prices, HLUBF is priced at $5.37, while TEVJF trades at $30.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TEVJF's P/E ratio is 24.95. In terms of profitability, HLUBF's ROE is +0.15%, compared to TEVJF's ROE of +0.21%. Regarding short-term risk, HLUBF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
HLUBF vs TAIPY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, HLUBF is priced at $5.37, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, HLUBF's ROE is +0.15%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, HLUBF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check TAIPY's competition here
HLUBF vs ESALY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HLUBF is priced at $5.37, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HLUBF's ROE is +0.15%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HLUBF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check ESALY's competition here
HLUBF vs BIOVF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BIOVF has a market cap of 16.4B. Regarding current trading prices, HLUBF is priced at $5.37, while BIOVF trades at $47.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BIOVF's P/E ratio is 169.11. In terms of profitability, HLUBF's ROE is +0.15%, compared to BIOVF's ROE of +0.02%. Regarding short-term risk, HLUBF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
HLUBF vs SGIOF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SGIOF has a market cap of 16.1B. Regarding current trading prices, HLUBF is priced at $5.37, while SGIOF trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SGIOF's P/E ratio is 14.99. In terms of profitability, HLUBF's ROE is +0.15%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, HLUBF and SGIOF have similar daily volatility (0.00).Check SGIOF's competition here
HLUBF vs SGIOY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SGIOY has a market cap of 15.9B. Regarding current trading prices, HLUBF is priced at $5.37, while SGIOY trades at $9.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SGIOY's P/E ratio is 14.80. In terms of profitability, HLUBF's ROE is +0.15%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, HLUBF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check SGIOY's competition here
HLUBF vs IPSEF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, HLUBF is priced at $5.37, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, HLUBF's ROE is +0.15%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, HLUBF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check IPSEF's competition here
HLUBF vs ESALF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ESALF has a market cap of 7.9B. Regarding current trading prices, HLUBF is priced at $5.37, while ESALF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ESALF's P/E ratio is 32.56. In terms of profitability, HLUBF's ROE is +0.15%, compared to ESALF's ROE of +0.04%. Regarding short-term risk, HLUBF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
HLUBF vs ESAIY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ESAIY has a market cap of 7B. Regarding current trading prices, HLUBF is priced at $5.37, while ESAIY trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ESAIY's P/E ratio is 28.09. In terms of profitability, HLUBF's ROE is +0.15%, compared to ESAIY's ROE of +0.04%. Regarding short-term risk, HLUBF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check ESAIY's competition here
HLUBF vs SFOSF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, HLUBF is priced at $5.37, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, HLUBF's ROE is +0.15%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, HLUBF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check SFOSF's competition here
HLUBF vs BCHMF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BCHMF has a market cap of 6.8B. Regarding current trading prices, HLUBF is priced at $5.37, while BCHMF trades at $91.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BCHMF's P/E ratio is 36.20. In terms of profitability, HLUBF's ROE is +0.15%, compared to BCHMF's ROE of +0.11%. Regarding short-term risk, HLUBF and BCHMF have similar daily volatility (0.00).Check BCHMF's competition here
HLUBF vs GZPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, HLUBF is priced at $5.37, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, HLUBF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
HLUBF vs HLBBF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HLBBF has a market cap of 5.2B. Regarding current trading prices, HLUBF is priced at $5.37, while HLBBF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HLBBF's P/E ratio is 12.84. In terms of profitability, HLUBF's ROE is +0.15%, compared to HLBBF's ROE of +0.15%. Regarding short-term risk, HLUBF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
HLUBF vs LVZPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, HLUBF is priced at $5.37, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, HLUBF's ROE is +0.15%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, HLUBF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
HLUBF vs SMDPY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SMDPY has a market cap of 4.9B. Regarding current trading prices, HLUBF is priced at $5.37, while SMDPY trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SMDPY's P/E ratio is 6.47. In terms of profitability, HLUBF's ROE is +0.15%, compared to SMDPY's ROE of +0.42%. Regarding short-term risk, HLUBF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check SMDPY's competition here
HLUBF vs DNPUF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, DNPUF has a market cap of 4.7B. Regarding current trading prices, HLUBF is priced at $5.37, while DNPUF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas DNPUF's P/E ratio is 6.21. In terms of profitability, HLUBF's ROE is +0.15%, compared to DNPUF's ROE of +0.42%. Regarding short-term risk, HLUBF and DNPUF have similar daily volatility (0.00).Check DNPUF's competition here
HLUBF vs LABFF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, HLUBF is priced at $5.37, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LABFF's P/E ratio is 28.95. In terms of profitability, HLUBF's ROE is +0.15%, compared to LABFF's ROE of +0.21%. Regarding short-term risk, HLUBF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
HLUBF vs SGFEF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, HLUBF is priced at $5.37, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SGFEF's P/E ratio is 20.49. In terms of profitability, HLUBF's ROE is +0.15%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, HLUBF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check SGFEF's competition here
HLUBF vs HKMPY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HKMPY has a market cap of 4.3B. Regarding current trading prices, HLUBF is priced at $5.37, while HKMPY trades at $39.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HKMPY's P/E ratio is 10.83. In terms of profitability, HLUBF's ROE is +0.15%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, HLUBF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
HLUBF vs HKMPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HKMPF has a market cap of 4.3B. Regarding current trading prices, HLUBF is priced at $5.37, while HKMPF trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HKMPF's P/E ratio is 11.02. In terms of profitability, HLUBF's ROE is +0.15%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HLUBF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
HLUBF vs APNHY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, APNHY has a market cap of 3.7B. Regarding current trading prices, HLUBF is priced at $5.37, while APNHY trades at $8.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas APNHY's P/E ratio is -33.60. In terms of profitability, HLUBF's ROE is +0.15%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, HLUBF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
HLUBF vs APNHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, HLUBF is priced at $5.37, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas APNHF's P/E ratio is -32.80. In terms of profitability, HLUBF's ROE is +0.15%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, HLUBF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
HLUBF vs LBTSF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, HLUBF is priced at $5.37, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, HLUBF's ROE is +0.15%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, HLUBF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
HLUBF vs CAMRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, HLUBF is priced at $5.37, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CAMRF's P/E ratio is 45.08. In terms of profitability, HLUBF's ROE is +0.15%, compared to CAMRF's ROE of +0.16%. Regarding short-term risk, HLUBF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
HLUBF vs HYPMY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, HLUBF is priced at $5.37, while HYPMY trades at $4.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HYPMY's P/E ratio is 8.44. In terms of profitability, HLUBF's ROE is +0.15%, compared to HYPMY's ROE of +0.13%. Regarding short-term risk, HLUBF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check HYPMY's competition here
HLUBF vs INVVY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HLUBF is priced at $5.37, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HLUBF's ROE is +0.15%, compared to INVVY's ROE of -0.42%. Regarding short-term risk, HLUBF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
HLUBF vs DMPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, DMPHF has a market cap of 2.9B. Regarding current trading prices, HLUBF is priced at $5.37, while DMPHF trades at $59.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas DMPHF's P/E ratio is 26.70. In terms of profitability, HLUBF's ROE is +0.15%, compared to DMPHF's ROE of +0.21%. Regarding short-term risk, HLUBF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
HLUBF vs IZQVF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HLUBF is priced at $5.37, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HLUBF's ROE is +0.15%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, HLUBF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
HLUBF vs CURLF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CURLF has a market cap of 2.6B. Regarding current trading prices, HLUBF is priced at $5.37, while CURLF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CURLF's P/E ratio is -23.36. In terms of profitability, HLUBF's ROE is +0.15%, compared to CURLF's ROE of -0.13%. Regarding short-term risk, HLUBF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CURLF's competition here
HLUBF vs ULIHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, HLUBF is priced at $5.37, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, HLUBF's ROE is +0.15%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, HLUBF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
HLUBF vs CHSYF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, HLUBF is priced at $5.37, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, HLUBF's ROE is +0.15%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, HLUBF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
HLUBF vs NPNKF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, HLUBF is priced at $5.37, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas NPNKF's P/E ratio is 11.78. In terms of profitability, HLUBF's ROE is +0.15%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, HLUBF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
HLUBF vs TSMRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, HLUBF is priced at $5.37, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, HLUBF's ROE is +0.15%, compared to TSMRF's ROE of +0.09%. Regarding short-term risk, HLUBF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
HLUBF vs HTSUF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, HLUBF is priced at $5.37, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, HLUBF's ROE is +0.15%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, HLUBF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
HLUBF vs ARSUF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, HLUBF is priced at $5.37, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, HLUBF's ROE is +0.15%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, HLUBF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
HLUBF vs DUTV Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, HLUBF is priced at $5.37, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas DUTV's P/E ratio is N/A. In terms of profitability, HLUBF's ROE is +0.15%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, HLUBF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check DUTV's competition here
HLUBF vs HMDCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HMDCF has a market cap of 1.9B. Regarding current trading prices, HLUBF is priced at $5.37, while HMDCF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HMDCF's P/E ratio is 4.08. In terms of profitability, HLUBF's ROE is +0.15%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, HLUBF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check HMDCF's competition here
HLUBF vs NPPNY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, NPPNY has a market cap of 1.8B. Regarding current trading prices, HLUBF is priced at $5.37, while NPPNY trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas NPPNY's P/E ratio is 9.65. In terms of profitability, HLUBF's ROE is +0.15%, compared to NPPNY's ROE of +0.11%. Regarding short-term risk, HLUBF is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check NPPNY's competition here
HLUBF vs GTBIF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GTBIF has a market cap of 1.7B. Regarding current trading prices, HLUBF is priced at $5.37, while GTBIF trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GTBIF's P/E ratio is 14.43. In terms of profitability, HLUBF's ROE is +0.15%, compared to GTBIF's ROE of +0.07%. Regarding short-term risk, HLUBF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check GTBIF's competition here
HLUBF vs SHPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, HLUBF is priced at $5.37, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, HLUBF's ROE is +0.15%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, HLUBF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
HLUBF vs CMOPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CMOPF has a market cap of 1.6B. Regarding current trading prices, HLUBF is priced at $5.37, while CMOPF trades at $103.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CMOPF's P/E ratio is -387.13. In terms of profitability, HLUBF's ROE is +0.15%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, HLUBF is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CMOPF's competition here
HLUBF vs MITPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HLUBF is priced at $5.37, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HLUBF's ROE is +0.15%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, HLUBF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check MITPF's competition here
HLUBF vs TCNNF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TCNNF has a market cap of 1.6B. Regarding current trading prices, HLUBF is priced at $5.37, while TCNNF trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TCNNF's P/E ratio is -20.27. In terms of profitability, HLUBF's ROE is +0.15%, compared to TCNNF's ROE of -0.07%. Regarding short-term risk, HLUBF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check TCNNF's competition here
HLUBF vs KARBF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HLUBF is priced at $5.37, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HLUBF's ROE is +0.15%, compared to KARBF's ROE of N/A. Regarding short-term risk, HLUBF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
HLUBF vs CASBF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, HLUBF is priced at $5.37, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CASBF's P/E ratio is 198.50. In terms of profitability, HLUBF's ROE is +0.15%, compared to CASBF's ROE of -0.00%. Regarding short-term risk, HLUBF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CASBF's competition here
HLUBF vs CHIZF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, HLUBF is priced at $5.37, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, HLUBF's ROE is +0.15%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, HLUBF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
HLUBF vs SWGHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, HLUBF is priced at $5.37, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, HLUBF's ROE is +0.15%, compared to SWGHF's ROE of +0.06%. Regarding short-term risk, HLUBF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
HLUBF vs KSPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, HLUBF is priced at $5.37, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas KSPHF's P/E ratio is 14.49. In terms of profitability, HLUBF's ROE is +0.15%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, HLUBF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
HLUBF vs TWAPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, HLUBF is priced at $5.37, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, HLUBF's ROE is +0.15%, compared to TWAPF's ROE of +0.03%. Regarding short-term risk, HLUBF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
HLUBF vs EVOTF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, EVOTF has a market cap of 1.2B. Regarding current trading prices, HLUBF is priced at $5.37, while EVOTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas EVOTF's P/E ratio is -5.27. In terms of profitability, HLUBF's ROE is +0.15%, compared to EVOTF's ROE of -0.25%. Regarding short-term risk, HLUBF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check EVOTF's competition here
HLUBF vs LJUIF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, HLUBF is priced at $5.37, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, HLUBF's ROE is +0.15%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, HLUBF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check LJUIF's competition here
HLUBF vs BIOGY Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, HLUBF is priced at $5.37, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, HLUBF's ROE is +0.15%, compared to BIOGY's ROE of +0.26%. Regarding short-term risk, HLUBF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
HLUBF vs SHEZF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, HLUBF is priced at $5.37, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, HLUBF's ROE is +0.15%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, HLUBF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
HLUBF vs KKPCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, HLUBF is priced at $5.37, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, HLUBF's ROE is +0.15%, compared to KKPCF's ROE of +0.01%. Regarding short-term risk, HLUBF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check KKPCF's competition here
HLUBF vs GNMLF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GNMLF has a market cap of 928.9M. Regarding current trading prices, HLUBF is priced at $5.37, while GNMLF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GNMLF's P/E ratio is 10.56. In terms of profitability, HLUBF's ROE is +0.15%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, HLUBF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
HLUBF vs GLASF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GLASF has a market cap of 847M. Regarding current trading prices, HLUBF is priced at $5.37, while GLASF trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GLASF's P/E ratio is -16.83. In terms of profitability, HLUBF's ROE is +0.15%, compared to GLASF's ROE of -0.26%. Regarding short-term risk, HLUBF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check GLASF's competition here
HLUBF vs CSWYF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, HLUBF is priced at $5.37, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, HLUBF's ROE is +0.15%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, HLUBF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CSWYF's competition here
HLUBF vs TRXPF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, HLUBF is priced at $5.37, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HLUBF's ROE is +0.15%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, HLUBF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
HLUBF vs YIHCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, HLUBF is priced at $5.37, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, HLUBF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
HLUBF vs AIHLF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, HLUBF is priced at $5.37, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, HLUBF's ROE is +0.15%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HLUBF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
HLUBF vs TRSSF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HLUBF is priced at $5.37, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HLUBF's ROE is +0.15%, compared to TRSSF's ROE of -0.75%. Regarding short-term risk, HLUBF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check TRSSF's competition here
HLUBF vs KHTRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, KHTRF has a market cap of 589.2M. Regarding current trading prices, HLUBF is priced at $5.37, while KHTRF trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas KHTRF's P/E ratio is 150.25. In terms of profitability, HLUBF's ROE is +0.15%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, HLUBF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
HLUBF vs SWDCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SWDCF has a market cap of 575.4M. Regarding current trading prices, HLUBF is priced at $5.37, while SWDCF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SWDCF's P/E ratio is 120.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HLUBF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
HLUBF vs AGYTF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, HLUBF is priced at $5.37, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, HLUBF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
HLUBF vs BOIRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BOIRF has a market cap of 553.9M. Regarding current trading prices, HLUBF is priced at $5.37, while BOIRF trades at $31.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BOIRF's P/E ratio is 24.17. In terms of profitability, HLUBF's ROE is +0.15%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, HLUBF is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check BOIRF's competition here
HLUBF vs PKBFF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, HLUBF is priced at $5.37, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HLUBF's ROE is +0.15%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HLUBF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
HLUBF vs NIKA Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, NIKA has a market cap of 534.8M. Regarding current trading prices, HLUBF is priced at $5.37, while NIKA trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas NIKA's P/E ratio is N/A. In terms of profitability, HLUBF's ROE is +0.15%, compared to NIKA's ROE of +0.27%. Regarding short-term risk, HLUBF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
HLUBF vs CCHWF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HLUBF is priced at $5.37, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HLUBF's ROE is +0.15%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, HLUBF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CCHWF's competition here
HLUBF vs VRNOF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, HLUBF is priced at $5.37, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, HLUBF's ROE is +0.15%, compared to VRNOF's ROE of -0.31%. Regarding short-term risk, HLUBF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check VRNOF's competition here
HLUBF vs PEXXF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HLUBF is priced at $5.37, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HLUBF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
HLUBF vs HUMDF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HUMDF has a market cap of 409.3M. Regarding current trading prices, HLUBF is priced at $5.37, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HUMDF's P/E ratio is 2.57. In terms of profitability, HLUBF's ROE is +0.15%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, HLUBF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
HLUBF vs ELTP Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ELTP has a market cap of 373.4M. Regarding current trading prices, HLUBF is priced at $5.37, while ELTP trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ELTP's P/E ratio is 8.67. In terms of profitability, HLUBF's ROE is +0.15%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, HLUBF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check ELTP's competition here
HLUBF vs CRLBF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CRLBF has a market cap of 312M. Regarding current trading prices, HLUBF is priced at $5.37, while CRLBF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CRLBF's P/E ratio is -2.39. In terms of profitability, HLUBF's ROE is +0.15%, compared to CRLBF's ROE of -0.35%. Regarding short-term risk, HLUBF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CRLBF's competition here
HLUBF vs CPHRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CPHRF has a market cap of 300.2M. Regarding current trading prices, HLUBF is priced at $5.37, while CPHRF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CPHRF's P/E ratio is 9.98. In terms of profitability, HLUBF's ROE is +0.15%, compared to CPHRF's ROE of +0.26%. Regarding short-term risk, HLUBF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CPHRF's competition here
HLUBF vs GUERF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, HLUBF is priced at $5.37, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GUERF's P/E ratio is 8.19. In terms of profitability, HLUBF's ROE is +0.15%, compared to GUERF's ROE of +0.04%. Regarding short-term risk, HLUBF and GUERF have similar daily volatility (0.00).Check GUERF's competition here
HLUBF vs BHCCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, HLUBF is priced at $5.37, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HLUBF's ROE is +0.15%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, HLUBF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check BHCCF's competition here
HLUBF vs PLNHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HLUBF is priced at $5.37, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HLUBF's ROE is +0.15%, compared to PLNHF's ROE of +838111.55%. Regarding short-term risk, HLUBF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check PLNHF's competition here
HLUBF vs CBWTF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CBWTF has a market cap of 150.7M. Regarding current trading prices, HLUBF is priced at $5.37, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CBWTF's P/E ratio is 10.74. In terms of profitability, HLUBF's ROE is +0.15%, compared to CBWTF's ROE of +0.16%. Regarding short-term risk, HLUBF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CBWTF's competition here
HLUBF vs COPHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HLUBF is priced at $5.37, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HLUBF's ROE is +0.15%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HLUBF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check COPHF's competition here
HLUBF vs NWPN Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, HLUBF is priced at $5.37, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas NWPN's P/E ratio is -0.04. In terms of profitability, HLUBF's ROE is +0.15%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HLUBF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check NWPN's competition here
HLUBF vs LOVFF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LOVFF has a market cap of 122.5M. Regarding current trading prices, HLUBF is priced at $5.37, while LOVFF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LOVFF's P/E ratio is 15.50. In terms of profitability, HLUBF's ROE is +0.15%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, HLUBF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
HLUBF vs BIOYF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, BIOYF has a market cap of 117.3M. Regarding current trading prices, HLUBF is priced at $5.37, while BIOYF trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas BIOYF's P/E ratio is 17.89. In terms of profitability, HLUBF's ROE is +0.15%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, HLUBF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check BIOYF's competition here
HLUBF vs LPCUF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, HLUBF is priced at $5.37, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, HLUBF's ROE is +0.15%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, HLUBF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check LPCUF's competition here
HLUBF vs CNVCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HLUBF is priced at $5.37, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, HLUBF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
HLUBF vs AAWH Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, AAWH has a market cap of 108.6M. Regarding current trading prices, HLUBF is priced at $5.37, while AAWH trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas AAWH's P/E ratio is -0.84. In terms of profitability, HLUBF's ROE is +0.15%, compared to AAWH's ROE of +5.41%. Regarding short-term risk, HLUBF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check AAWH's competition here
HLUBF vs HLTRF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, HLTRF has a market cap of 102M. Regarding current trading prices, HLUBF is priced at $5.37, while HLTRF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas HLTRF's P/E ratio is -10.19. In terms of profitability, HLUBF's ROE is +0.15%, compared to HLTRF's ROE of -0.17%. Regarding short-term risk, HLUBF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check HLTRF's competition here
HLUBF vs ORXOF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, HLUBF is priced at $5.37, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ORXOF's P/E ratio is -2.27. In terms of profitability, HLUBF's ROE is +0.15%, compared to ORXOF's ROE of -2.28%. Regarding short-term risk, HLUBF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
HLUBF vs GRUSF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, GRUSF has a market cap of 98.6M. Regarding current trading prices, HLUBF is priced at $5.37, while GRUSF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas GRUSF's P/E ratio is 39.46. In terms of profitability, HLUBF's ROE is +0.15%, compared to GRUSF's ROE of +0.01%. Regarding short-term risk, HLUBF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check GRUSF's competition here
HLUBF vs JUSHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, JUSHF has a market cap of 97M. Regarding current trading prices, HLUBF is priced at $5.37, while JUSHF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas JUSHF's P/E ratio is -1.35. In terms of profitability, HLUBF's ROE is +0.15%, compared to JUSHF's ROE of +0.66%. Regarding short-term risk, HLUBF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check JUSHF's competition here
HLUBF vs MEDXF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, MEDXF has a market cap of 91.1M. Regarding current trading prices, HLUBF is priced at $5.37, while MEDXF trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas MEDXF's P/E ratio is -141.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, HLUBF and MEDXF have similar daily volatility (0.00).Check MEDXF's competition here
HLUBF vs SHIEF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, SHIEF has a market cap of 85.5M. Regarding current trading prices, HLUBF is priced at $5.37, while SHIEF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas SHIEF's P/E ratio is -4.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, HLUBF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
HLUBF vs ABSCF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, ABSCF has a market cap of 78.1M. Regarding current trading prices, HLUBF is priced at $5.37, while ABSCF trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas ABSCF's P/E ratio is -37.33. In terms of profitability, HLUBF's ROE is +0.15%, compared to ABSCF's ROE of +0.07%. Regarding short-term risk, HLUBF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check ABSCF's competition here
HLUBF vs CWBHF Comparison May 2026
HLUBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLUBF stands at 5.7B. In comparison, CWBHF has a market cap of 73.9M. Regarding current trading prices, HLUBF is priced at $5.37, while CWBHF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLUBF currently has a P/E ratio of 9.26, whereas CWBHF's P/E ratio is -2.00. In terms of profitability, HLUBF's ROE is +0.15%, compared to CWBHF's ROE of -20.65%. Regarding short-term risk, HLUBF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLUBF.Check CWBHF's competition here